NAN Alerts

Observe for Possible Fluid Leakage When Preparing Parenteral Syringes

The Institute for Safe Medication Practices (ISMP) has heard from three hospitals about occasional instances of medication leaking from syringes. Leaks have extended past the first and second rib on the black stopper on the parenteral syringe plunger rod into the surface of the syringe barrel that is exposed to air (Figure 1). The situation appears to occur as liquid is drawn into the syringe rather than after the syringe has been filled. In some cases, personnel said that it has happened rarely, and they may not have realized the situation was out of the ordinary, so instances may have gone unreported.

syringe plunger

The reported syringes have been manufactured by BD, and both the company and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) are aware of the situation. We are not certain if this issue may also involve syringes from other manufacturers. While syringes in the reported cases have been of varying sizes, BD reports that the syringes involved in its review have predominantly been the 10 mL size. There is a corrective action project underway to address the issue with the 10 mL syringes.

In assessments BD has made, the company found that leakage into the area between the first and second ribs of the stopper retains the sterility of the fluid and in most instances has no impact on the volumetric accuracy of the delivery of the medication.

Proper user technique when preparing syringes can be helpful in preventing this situation, especially with larger syringe sizes (e.g., 30 mL and 60 mL). As a syringe is being filled with the vial inverted and the syringe below the vial, there may be a tendency to pull the plunger rod at an angle toward the user and not always maintain a vertical alignment with the syringe barrel. With an increased amount of fluid in the syringe, the ribs of the stopper may be angled enough to cause leakage past the stopper ribs. BD says that it is always important to ensure vertical alignment of the plunger rod with the syringe barrel when withdrawing a solution using this inverted vial technique.

ISMP recommends sharing this information with sterile syringe production personnel and clinical personnel who prepare medications in parenteral syringes. Ask them to always observe prepared syringes for this situation. If leakage is observed beyond the first and second ribs of the stopper and into the area exposed to air, the syringe and medication may have been contaminated and should not be used. Additional precautions to avoid contaminating work surfaces and exposing personnel are required if leaking syringes contain hazardous drugs.

If a leaking syringe is identified, the syringe lot number should be identified and recorded, and such instances should be reported to the FDA MedWatch Program, the ISMP National Medication Errors Reporting Program (ISMP MERP), and the syringe manufacturer.

More Alerts

B. Braun recently announced a new presentation of potassium chloride for injection concentrate (2 mEq/mL) in a 250 mL EXCEL container plastic bag with blue and red labeling, and a blocked medication port. The 250 mL product is a pharmacy bulk package and should only be used in a pharmacy admixture
On December 22, 2021, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for PAXLOVID, consisting of oral tablets of nirmatrelvir that are co-packaged with oral tablets of ritonavir (an FDA-approved antiretroviral agent). Indications Emergency use of Paxlovid is
Ever since the US Food and Drug Administration (FDA) authorized the emergency use of a specific formulation (10 mcg/0.2 mL) of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine for children ages 5 through 11 years, reports of mix-ups with the Pfizer-BioNTech COVID-19 vaccine